Neuberger Berman Group
EW icon

Neuberger Berman Group’s Edwards Lifesciences EW Stock Holding History

Neuberger Berman Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188M Buy
2,350,179
+2,021,413
+615% +$167M 0.14% 158
2025
Q4 		$28M Sell
328,766
-15,637
-5% -$1.28M 0.02% 586
2025
Q3 		$26.8M Sell
344,403
-8,243
-2% -$644K 0.02% 592
2025
Q2 		$27.6M Sell
352,646
-5,480
-2% -$409K 0.02% 568
2025
Q1 		$26M Sell
358,126
-149,685
-29% -$10.7M 0.02% 563
2024
Q4 		$37.6M Sell
507,811
-31,320
-6% -$2.19M 0.03% 511
2024
Q3 		$35.6M Sell
539,131
-885,715
-62% -$64.4M 0.03% 516
2024
Q2 		$132M Sell
1,424,846
-26,268
-2% -$2.33M 0.11% 230
2024
Q1 		$139M Sell
1,451,114
-43,636
-3% -$3.67M 0.11% 229
2023
Q4 		$114M Sell
1,494,750
-431,170
-22% -$30M 0.1% 259
2023
Q3 		$133M Buy
1,925,920
+31,731
+2% +$2.55M 0.12% 216
2023
Q2 		$179M Buy
1,894,189
+7,329
+0.4% +$637K 0.16% 165
2023
Q1 		$156M Sell
1,886,860
-61,362
-3% -$4.82M 0.14% 186
2022
Q4 		$145M Buy
1,948,222
+59,879
+3% +$4.61M 0.14% 200
2022
Q3 		$156M Sell
1,888,343
-897
-0% -$86.3K 0.16% 177
2022
Q2 		$180M Sell
1,889,240
-16,742
-0.9% -$1.73M 0.18% 165
2022
Q1 		$224M Sell
1,905,982
-494,837
-21% -$55.5M 0.19% 143
2021
Q4 		$310M Buy
2,400,819
+540,439
+29% +$63M 0.24% 102
2021
Q3 		$209M Sell
1,860,380
-23,334
-1% -$2.66M 0.18% 156
2021
Q2 		$194M Sell
1,883,714
-222,610
-11% -$21M 0.17% 171
2021
Q1 		$176M Sell
2,106,324
-456,243
-18% -$38.6M 0.17% 186
2020
Q4 		$233M Buy
2,562,567
+7,913
+0.3% +$656K 0.24% 112
2020
Q3 		$204M Buy
2,554,654
+14,653
+0.6% +$1.14M 0.24% 109
2020
Q2 		$175M Buy
2,540,001
+5,733
+0.2% +$407K 0.22% 127
2020
Q1 		$159M Buy
2,534,268
+242,730
+11% +$17.5M 0.24% 105
2019
Q4 		$178M Sell
2,291,538
-49,077
-2% -$3.83M 0.21% 136
2019
Q3 		$172M Sell
2,340,615
-67,338
-3% -$4.73M 0.21% 139
2019
Q2 		$148M Sell
2,407,953
-101,448
-4% -$6.13M 0.18% 162
2019
Q1 		$160M Sell
2,509,401
-296,178
-11% -$16.9M 0.2% 142
2018
Q4 		$143M Buy
2,805,579
+724,458
+35% +$36.7M 0.2% 140
2018
Q3 		$121M Buy
2,081,121
+39,780
+2% +$1.95M 0.14% 220
2018
Q2 		$99.1M Sell
2,041,341
-432,357
-17% -$20.2M 0.11% 264
2018
Q1 		$115M Sell
2,473,698
-270,717
-10% -$11.8M 0.13% 227
2017
Q4 		$103M Buy
2,744,415
+14,421
+0.5% +$529K 0.12% 258
2017
Q3 		$99.5M Buy
2,729,994
+53,583
+2% +$2.04M 0.12% 253
2017
Q2 		$105M Sell
2,676,411
-39,336
-1% -$1.44M 0.14% 228
2017
Q1 		$85.2M Sell
2,715,747
-565,185
-17% -$17.7M 0.11% 270
2016
Q4 		$102M Buy
3,280,932
+1,997,592
+156% +$64.7M 0.14% 234
2016
Q3 		$51.6M Buy
1,283,340
+115,161
+10% +$4.34M 0.07% 370
2016
Q2 		$38.8M Buy
1,168,179
+210,936
+22% +$7.22M 0.05% 429
2016
Q1 		$28.1M Buy
957,243
+491,025
+105% +$13.5M 0.04% 503
2015
Q4 		$12.3M Buy
466,218
+9,498
+2% +$247K 0.02% 724
2015
Q3 		$10.8M Buy
456,720
+390
+0.1% +$9.41K 0.01% 766
2015
Q2 		$10.8M Buy
456,330
+43,206
+10% +$975K 0.01% 811
2015
Q1 		$9.81M Sell
413,124
-138,054
-25% -$3.1M 0.01% 837
2014
Q4 		$11.7M Sell
551,178
-101,502
-16% -$2.04M 0.01% 794
2014
Q3 		$11.1M Buy
652,680
+156,012
+31% +$2.46M 0.01% 817
2014
Q2 		$7.11M Sell
496,668
-502,044
-50% -$6.81M 0.01% 912
2014
Q1 		$12.3M Sell
998,712
-6,076,686
-86% -$70.1M 0.01% 759
2013
Q4 		$77.5M Sell
7,075,398
-925,302
-12% -$10.4M 0.08% 353
2013
Q3 		$92.8M Sell
8,000,700
-2,974,044
-27% -$34.8M 0.1% 294
2013
Q2 		$123M Buy
+10,974,744
New +$130M 0.15% 209

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group's EW Position: Q1 2026 in Review

Neuberger Berman Group increased its Edwards Lifesciences (EW) stake by 615% in Q1 2026, buying an estimated $167M and bringing the position to 2,350,179 shares worth $188M. The position accounts for 0.14% of the portfolio, ranked #158.

Neuberger Berman Group first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $310M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Neuberger Berman Group held 2,350,179 shares of Edwards Lifesciences worth $188M as of Q1 2026.
  • Neuberger Berman Group bought 2,021,413 Edwards Lifesciences shares in Q1 2026, an estimated $167M.
  • Edwards Lifesciences made up 0.14% of Neuberger Berman Group's portfolio in Q1 2026, its #158 holding.
  • Neuberger Berman Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Edwards Lifesciences position peaked at $310M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.